IDYA (IDYA) Stock Price & Analysis
IDYA (IDYA) fell 0.28% to USD 39.86 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
IDYA last closed at USD 39.86; the session ranged USD 39.42–40.07 on volume of 448,007 shares. Market capitalization is —, with a 52-week range of USD 23.53–42.68 (NMS). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 39.86 |
|---|---|
| Change | ▼ 0.28% (down) |
| Previous Close | USD 39.86 |
| Open | USD 39.86 |
| Day Range | USD 39.42 – 40.07 |
| 52-Week Range | USD 23.53 – 42.68 |
| Volume | 448,007 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IDYA)
Nexqual's technical model rates IDYA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.29 (neutral) |
| vs SMA50 | Above (USD 37.58) |
| MACD | 1.05 (positive) |
From IDYA's Latest SEC 10-K Filing (filed 2026-02-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| BCYC | Bicycle Therapeutics plc | USD 4.3 | ▲ 0% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| MIRM | Mirum Pharmaceuticals, Inc. | USD 100.9 | ▲ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.